The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic… read more.
by Gary Finnegan – EMA Highlights – The first radiopharmaceutical for positron emission tomography (PET) imaging of β-amyloid neuritic plaque density has been approved by the EMA’s Committee… read more.
by Gary Finnegan – World Health Matters (Canada) – Austerity measures introduced by European governments and the deepening threat of insolvency faced by the US Medicare system have… read more.
by Gary Finnegan – World Health Matters (France) – A new study has suggested that low levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3… read more.
by Gary Finnegan – World Health Matters (France) – A new study has suggested that low levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3… read more.
It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The EMA has given the green light for the first medicine specifically for irritable bowel syndrome (IBS)… read more.
by Maria Dalby – Donating a kidney in later life can have a positive effect on quality of life, according to the largest study to date on this… read more.
The Brussels Declaration, published in the European Respiratory Journal in 2008 recognises the high prevalence of patients with poorly controlled asthma and calls for changes in asthma management… read more.
by Zara Qadir – ESC Geoffrey Rose Lecture on Population Sciences. The recipient of the ‘ESC Geoffrey Rose Lecture on Population Sciences’ went to Rory Collins (pictured), who… read more.
by Thomas R. Collins – The functional status of transplant recipients is a factor that is often overlooked as kidneys are allocated,
by Zara Qadir reporting on the presentation by Professor Petra Thürmann (pictured) from the Philipp Klee-Institute of Clinical Pharmacology at the HELIOS Klinikum Wuppertal in Germany.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
